A start-up company focused on digital health has launched with a series A financing round worth $20 million.
Incubated at Providence, Praia Health has received investments from Frist Cressey Ventures, as well as SignalFire, Epsilon Health Investors and Providence Ventures in the fundraise.
The company is focused on removing barriers to patient care by automatically connecting people with healthcare products and services.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze